Michael Brown, MD
Gastroenterology · Decatur, ALNPI 1962491092
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $832 and has fallen 93.2% since, to $57 in 2025. That places this record below the midpoint for gastroenterology clinicians in AL, where the typical reported total is $3,384.
Across 121 payments — averaging $14.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$350
- AbbVie$287
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$238
- Takeda Pharmaceuticals U.S.A., Inc.$172
- Nestle Healthcare Nutrition Inc.$167
- Ironwood Pharmaceuticals, Inc$120
- plus $380 from 9 others
Across 194 payments — averaging $8603.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$895K
- Intercept Pharmaceuticals, Inc.$281K
- Braintree Laboratories, Inc.$221K
- Novartis$93K
- Boehringer Ingelheim$93K
- E.r. Squibb & Sons, L.L.C.$66K
- plus $20K from 2 others
What the payments were for
- Food & beverage$1,709100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $350 |
| AbbVie(2 entities) | 19 | $287 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $172 |
| Nestle Healthcare Nutrition Inc. | 19 | $167 |
| Ironwood Pharmaceuticals, Inc | 8 | $120 |
| Myriad Genetic Laboratories, Inc. | 6 | $97 |
| Boston Scientific | 3 | $85 |
| UCB, Inc. | 6 | $69 |
| Biocompatibles, Inc. | 2 | $45 |
| Concordia Pharmaceuticals Inc. | 1 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| QOL Medical, LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Bayer | 1 | $11 |
How this compares
$1,714 in reported general payments places this provider in the 30th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Decatur
- Robert ShafferBirmingham$1M
- Jack DipalmaMobile$903K
- Phillip HendersonMobile$462K
- Travis RutlandDothan$302K
- Viplove SenadhiMontgomery$282K
- Mukul MehraBirmingham$193K
- William SonnierMobile$178K
- Jorge HerreraMobile$167K
- Meagan GrayBirmingham$113K
- Paul LambDothan$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.